Genexine, Inc. (KOSDAQ:095700)

Genexine Revenue

Genexine had revenue of 2.07B KRW in the quarter ending March 31, 2024, with 199.63% growth. This brings the company's revenue in the last twelve months to 5.81B, down -3.50% year-over-year. In the year 2023, Genexine had annual revenue of 4.43B, down -72.57%.

• Revenue (ttm): 5.81B
• Revenue Growth: -3.50%
• P/S Ratio: 23.57
• Revenue / Employee: 67.53M
• Employees: 86
• Market Cap: 136.89B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	4.43B	-11.71B	-72.57%
Dec 31, 2022	16.14B	-20.69B	-56.18%
Dec 31, 2021	36.83B	18.28B	98.61%
Dec 31, 2020	18.54B	7.24B	64.06%
Dec 31, 2019	11.30B	5.05B	80.80%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2024

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 7, 2026

Data Sources Report a data error